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     Dopamine receptors can be divided into two major families: the D1-like and D2-like receptors based on 
their  pharmacological  profiles  and  coupling  with  the  enzyme  adenylate  cyclase.1  Molecular  cloning 
techniques have shown that the D1-like family is further divided into D1 and D5 receptors, both of which 
activate adenylate cyclase, while the D2-like family is divided into D2, D3 and D4 receptors, which either 
inhibit cyclic adenosine monophosophate (cAMP) production or are not coupled to adenylate cyclase.2 
Psychotic disorders, such as schizophrenia, seem to be characterized  by an overactivity of dopamine-
secreting neurons  in the ‘limbic brain’, rich in D2-like receptors.3 From a pharmacological point of view 
D2 receptor antagonist have been shown to treat these diseases effectively; however, a long term treatment 
is associated with the induction of disabling side effects such as extrapyramidal  syndrome (EPS) and 
irreversible tardive dyskinesia. The therapeutic benefit of D2 antagonists in treating psychotics disorders 
has  been  fully  accepted  with  the  discovery  of  more  effective  antipsychotic  drugs  characterized  by 
minimal induction of extrapyramidal effects (atypical antipsychotic).3 Therefore the synthesis of novel 
antipsychotic with a better  pharmacological profile remains a primary goal in the research for the therapy 
of psychoses.3
     In previous papers4a,b we have reported the syntheses and structure-activity relationships of a series of 
5-phenyl-3-pyrrole carboxamide and related 4,5-dihydrobenzo[g]indole-3-carboxamide analogues whose 
most representative terms were 1a and 2a respectively.
R1
1   IC50= 1030 µ M







2   IC50= 160 nM
X = CH2, R = R









     Encouraged by these results we carried out several modifications of 2a. A first objective of this study 
was to seek correlations between the electronic and hydrophobic properties of the benzene and pyrrole 
substituents as well as to evaluate the bioisosteric replacement CH2/S in the ethylenic bridge with a view 
to determining those physicochemical parameters which contribute to D2-like binding affinity. Moreover, 
the spatial arrangement of the two aryl/heteroaryl rings of 2a would be expected to influence bioactivity 
profoundly; thus the preparation of 1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[b]pyrrole analogues was also 
contemplated and their biological evaluation should permit some understanding of the importance of the 
relative positions of the aryl/heteroaryl rings. 
     The synthesis of the new benzo[g]indole-3-carboxamide derivatives and related compounds, 2b-k and 
their in vitro binding to the dopamine D2-like receptors are reported. 
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2         a       b        c        d           e            f             g           h       i         j               k
X      CH2   CH2   CH2     CH2     CH2       CH2        CH2      CH2    S   CH2CH2   CH2CH2
R        H      H        H        H         H           H   H          Cl     H       H              Cl
R1       H    6-Cl    7-Cl    8-Cl    7,8-Cl2   8-CH3   7-OCH3     H      H       H              H 
